ALISO VIEJO, Calif., April 15, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its first quarter 2008 financial results on Tuesday, May 13, 2008 prior to the market open. A conference call to review the results will follow at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). This call will be open to all investors live via the Investor Relations section of the SenoRx Web site at www.senorx.com. A replay of the call will be available on the company's web site approximately 90 minutes after the call concludes. It will also be available to be downloaded as a podcast.
Details:
What: SenoRx's 2008 First Quarter Financial Results Conference Call
and Webcast
Date: Tuesday, May 13
Time: 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time
How: Via telephone: Domestic: 877-545-1402; International:
719-325-4890 Via Internet: www.senorx.com
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its flagship EnCor(r) system and Contura(tm) MLB. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605